Gamunex-c 20 gram/200 ML vial 200ML
Ended Awarded Last action
- Contract number
- SPE2DR26F9GE8
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,365
Award facts
- Contract value 100% obligated
- $11,365.12 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 17, 2025, for the supply of Gamunex-C, a 20 gram/200 milliliter immunoglobulin vial product. This firm fixed-price delivery order, valued at $11,365.12, is scheduled for completion by January 9, 2026, and will be fulfilled from the vendor's Conshohocken, Pennsylvania location. The contract was awarded competitively with no set-aside designation, reflecting open competition among qualified pharmaceutical suppliers. This delivery order is a child contract issued under AmerisourceBergen's broader Indefinite Delivery Contract (SPE2DX) with DLA Troop Support Medical, which is valued at $999,999,999.00 and extends through December 2026.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Pennsylvania, serves as a critical federal vendor for military and veteran healthcare systems through its comprehensive medical supply portfolio. The company's existing IDC vehicle with DLA supports global pharmaceutical needs for the Defense Health Agency, U.S. Coast Guard, and other government healthcare systems, encompassing specialty medications, vaccines, and medical devices across multiple therapeutic domains. The current delivery order for Gamunex-C, an immunoglobulin product used for immunodeficiency treatment, exemplifies the company's role in supplying specialized pharmaceutical commodities to support federal medical procurement requirements.
Quick answers
Who was awarded contract SPE2DR26F9GE8?
SPE2DR26F9GE8 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on December 17, 2025.
How much is contract SPE2DR26F9GE8 worth?
The government has obligated $11,365 on SPE2DR26F9GE8.
Is contract SPE2DR26F9GE8 an order under another contract?
Yes. SPE2DR26F9GE8 is a delivery order under SPE2DR25D2206, an indefinite delivery contract.
Was contract SPE2DR26F9GE8 competed?
The extent of competition for SPE2DR26F9GE8 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award